BHAGERIA
Bhageria Industries Limited
Specialty organic and inorganic chemicals, solar power and pharmaceuticals producer
Commodities›Chemicals›Chemicals & Petrochemicals›Dyes And Pigments
bhageriagroup.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Bhageria Industries makes dye intermediates and specialty chemicals, mainly H-acid, vinyl sulphone and gamma acid, sold to dye manufacturers that serve textile and leather customers, and it also runs solar power and pharmaceutical businesses.
Company snapshot
5thBy market cap
Ranked among 11 companies in Dyes And Pigments.
Segment mix
Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.
Largest segment: 83.1% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Chemical | 83.1% | 143 Cr | 22 Cr | 485 Cr |
| Other | 12.8% | 22 Cr | -3 Cr | 64 Cr |
| Solar Power | 4.2% | 7 Cr | 3 Cr | 121 Cr |
What we see
- ✓Debt-to-equity of 0.17x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 103 Cr | 112 Cr | 182 Cr | 113 Cr | 129 Cr | 170 Cr | 183 Cr | 157 Cr | 204 Cr | 242 Cr | 271 Cr | 286 Cr |
| Operating expenses (approx.) | 94 Cr | 98 Cr | 168 Cr | 101 Cr | 116 Cr | 143 Cr | 153 Cr | 140 Cr | 181 Cr | 222 Cr | 240 Cr | 244 Cr |
| EBITDA | 8 Cr | 14 Cr | 14 Cr | 12 Cr | 14 Cr | 27 Cr | 29 Cr | 18 Cr | 23 Cr | 20 Cr | 31 Cr | 42 Cr |
| OPM % | 8.2% | 12.5% | 7.9% | 10.3% | 10.5% | 15.8% | 16.1% | 11.2% | 11.3% | 8.2% | 11.3% | 14.7% |
| Other income | 4 Cr | 6 Cr | 4 Cr | 5 Cr | 3 Cr | -2 Cr | 0.99 Cr | 6 Cr | 2 Cr | 3 Cr | -4 Cr | 16 Cr |
| Interest | 0.41 Cr | 0.30 Cr | 0.52 Cr | 0.76 Cr | 0.54 Cr | 0.77 Cr | 0.73 Cr | 0.99 Cr | 0.75 Cr | 0.74 Cr | 0.94 Cr | 2 Cr |
| Depreciation | 8 Cr | 8 Cr | 8 Cr | 7 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 9 Cr | 10 Cr |
| Profit before tax | 4 Cr | 11 Cr | 10 Cr | 8 Cr | 8 Cr | 16 Cr | 22 Cr | 15 Cr | 16 Cr | 14 Cr | 17 Cr | 46 Cr |
| Tax % | 29.5% | 28.2% | 33.6% | 27.7% | 24.4% | 29.5% | 29.9% | 29.4% | 28.6% | 21.5% | 32.3% | 26.4% |
| Net profit | 3 Cr | 8 Cr | 6 Cr | 6 Cr | 6 Cr | 11 Cr | 15 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr | 34 Cr |
| EPS (₹) | ₹0.63 | ₹1.89 | ₹1.55 | ₹1.36 | ₹1.50 | ₹2.78 | ₹3.61 | ₹2.58 | ₹2.70 | ₹2.56 | ₹2.71 | ₹7.83 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 402 Cr | 601 Cr | 501 Cr | 494 Cr | 595 Cr | 874 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 298 Cr | 485 Cr | 447 Cr | 451 Cr | 513 Cr | 783 Cr | Sign in free for the trailing twelve months |
| EBITDA | 104 Cr | 116 Cr | 54 Cr | 43 Cr | 81 Cr | 91 Cr | Sign in free for the trailing twelve months |
| OPM % | 25.8% | 19.4% | 10.9% | 8.7% | 13.7% | 10.4% | Sign in free for the trailing twelve months |
| Other income | 4 Cr | 9 Cr | 4 Cr | 17 Cr | 7 Cr | 7 Cr | Sign in free for the trailing twelve months |
| Interest | 1 Cr | 2 Cr | 4 Cr | 2 Cr | 3 Cr | 3 Cr | Sign in free for the trailing twelve months |
| Depreciation | 26 Cr | 29 Cr | 34 Cr | 32 Cr | 31 Cr | 33 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 81 Cr | 95 Cr | 20 Cr | 26 Cr | 54 Cr | 62 Cr | Sign in free for the trailing twelve months |
| Tax % | 22.7% | 25.9% | 27.8% | 29.5% | 28.6% | 28.2% | Sign in free for the trailing twelve months |
| Net profit | 63 Cr | 71 Cr | 15 Cr | 19 Cr | 39 Cr | 44 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹14.36 | ₹16.17 | ₹3.38 | ₹4.37 | ₹9.26 | ₹10.56 | Sign in free for the trailing twelve months |
| Dividend payout % | 21.0% | 21.7% | 118.8% | 23.6% | 11.3% | 14.7% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 22 Cr | 22 Cr | 22 Cr | 22 Cr | 22 Cr | 22 Cr |
| Reserves | 430 Cr | 485 Cr | 484 Cr | 501 Cr | 536 Cr | 575 Cr |
| Borrowings | 31 Cr | 35 Cr | 38 Cr | 47 Cr | 45 Cr | 101 Cr |
| Other liabilities | 92 Cr | 104 Cr | 87 Cr | 106 Cr | 132 Cr | 166 Cr |
| Total liabilities | 575 Cr | 646 Cr | 631 Cr | 676 Cr | 733 Cr | 860 Cr |
| Fixed assets (net) | 318 Cr | 392 Cr | 363 Cr | 345 Cr | 348 Cr | 383 Cr |
| CWIP | 45 Cr | 0.01 Cr | 8 Cr | 17 Cr | 11 Cr | 117 Cr |
| Investments | 6 Cr | 10 Cr | 15 Cr | 27 Cr | 24 Cr | 25 Cr |
| Loans & advances | 0.27 Cr | 0.26 Cr | 0.44 Cr | 0.50 Cr | 0.54 Cr | 1 Cr |
| Inventories | 38 Cr | 65 Cr | 43 Cr | 44 Cr | 49 Cr | 56 Cr |
| Trade receivables | 95 Cr | 104 Cr | 127 Cr | 156 Cr | 187 Cr | 159 Cr |
| Cash & bank | 18 Cr | 22 Cr | 11 Cr | 6 Cr | 2 Cr | 5 Cr |
| Other assets | 54 Cr | 53 Cr | 63 Cr | 80 Cr | 111 Cr | 114 Cr |
| Total assets | 575 Cr | 646 Cr | 631 Cr | 676 Cr | 733 Cr | 860 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 58 Cr | 76 Cr | 28 Cr | 23 Cr | 52 Cr | 99 Cr |
| Cash from investing | -44 Cr | -58 Cr | -23 Cr | -33 Cr | -46 Cr | -141 Cr |
| Cash from financing | -3 Cr | -14 Cr | -16 Cr | 5 Cr | -9 Cr | 46 Cr |
| Net cash flow | 10 Cr | 4 Cr | -11 Cr | -5 Cr | -3 Cr | 3 Cr |
| Free cash flow (OCF − Capex) | 18 Cr | 17 Cr | 14 Cr | -4 Cr | 25 Cr | -45 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 17.0% | 17.9% | 4.4% | 4.9% | 9.5% | 9.4% |
| ROE % | 13.9% | 13.9% | 2.9% | 3.7% | 7.3% | 7.8% |
| Debtor days | 86 | 63 | 93 | 115 | 114 | 66 |
| Inventory days | 72 | 71 | 46 | 66 | 58 | 38 |
| Days payable | 71 | 56 | 43 | 91 | 81 | 50 |
| Cash conversion cycle | 88 | 78 | 96 | 91 | 92 | 54 |
| OCF / EBITDA % | 56.0% | 65.0% | 50.7% | 53.4% | 64.0% | 108.0% |
| OCF / EBITDA % (3 years) | — | — | 58.7% | 59.0% | 57.4% | 80.5% |
| Debt / equity | 0.07 | 0.07 | 0.08 | 0.09 | 0.08 | 0.17 |
| Current ratio | 2.43 | 2.51 | 2.83 | 2.74 | 2.68 | 2.19 |
| Net debt / EBITDA | 0.13 | 0.11 | 0.50 | 0.97 | 0.52 | 1.05 |